Difference between revisions of "DS Brar"
Jump to navigation
Jump to search
(new) |
(Sun Pharmaceuticals) |
||
| Line 1: | Line 1: | ||
In 2011 "[[Kohlberg Kravis Roberts]] & Co. (KKR), the global private equity giant with $61.9 billion under management, has appointed former [[Ranbaxy Laboratories]] CEO DS Brar as a senior advisor." [https://www.vccircle.com/kkr-adds-former-ranbaxy-ceo-ds-brar-senior-advisor/] | In 2011 "[[Kohlberg Kravis Roberts]] & Co. (KKR), the global private equity giant with $61.9 billion under management, has appointed former [[Ranbaxy Laboratories]] CEO DS Brar as a senior advisor." [https://www.vccircle.com/kkr-adds-former-ranbaxy-ceo-ds-brar-senior-advisor/] | ||
| + | |||
| + | "Brar, who worked with Ranbaxy from 1977 to 2004, played a pivotal role in making it India's largest drug maker with an extensive international footprint. He was closely associated with [[Parvinder Singh]], the late chairman and managing director of the company that [[Sun Pharmaceuticals]] is taking over from Japan's Daiichi Sankyo in a record $4-billion deal." [https://economictimes.indiatimes.com/wealth/personal-finance-news/ranbaxy-ex-ceo-ds-brar-may-buy-bungalow-in-lutyens/articleshow/42222472.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst] | ||
| + | |||
| + | *Former chairman of [[GVK Bio]] | ||
==Resources and articles== | ==Resources and articles== | ||
Revision as of 18:40, 19 April 2020
In 2011 "Kohlberg Kravis Roberts & Co. (KKR), the global private equity giant with $61.9 billion under management, has appointed former Ranbaxy Laboratories CEO DS Brar as a senior advisor." [1]
"Brar, who worked with Ranbaxy from 1977 to 2004, played a pivotal role in making it India's largest drug maker with an extensive international footprint. He was closely associated with Parvinder Singh, the late chairman and managing director of the company that Sun Pharmaceuticals is taking over from Japan's Daiichi Sankyo in a record $4-billion deal." [2]
- Former chairman of GVK Bio
